ライフサイエンスコーパス: complete blood count

1 from each patient for measurement of BLL and complete blood count.

2 (PI); 4) gingival index (GI); 5) CRP; and 6) complete blood count.

3 city was quantified via body weight loss and complete blood count.

4 d hematoanalyzer and reported as part of the complete blood count.

5 coagulation studies, serum chemistries, and complete blood counts.

6 poietic reconstitution was assessed by doing complete blood counts.

7 can be identified in individuals with normal complete blood counts.

8 t times from 4-23 days post-treatment, and a complete blood count along with blood chemistry analyses

9 e and on-treatment NLRs were calculated from complete blood counts among 60 087 participants randomiz

10 Complete blood count analysis demonstrated that disrupti

11 of 48 routinely obtained blood specimens for complete blood count analysis in our institutional labor

12 y obtained from 48 hospitalized patients for complete blood count analysis.

13 the cardiac surgical intensive care unit for complete blood count analysis.

14 ngs and routine laboratory values, including complete blood count and basic metabolic panels, were no

15 Her complete blood count and basic metabolic profile were un

16 All other work-up, including complete blood count and chest radiography, yielded nega

17 imple, widely available blood tests, such as complete blood count and complete metabolic panel, could

18 ng system that utilizes routine blood tests (complete blood count and comprehensive metabolic profile

19 g a new allopurinol prescription, and QI 3 = complete blood count and creatine kinase check every 6 m

20 Laboratory findings, including a complete blood count and creatinine, C-reactive protein,

21 Laboratory test results, including complete blood count and electrolyte, creatinine, creati

22 ucted with AP NAAT results and time-adjacent complete blood count and LFT results for adult patients

23 -organ function cluster, vital-sign cluster, complete blood count and sodium clusters.

24 1,2-HOPO-Davisil did not change complete blood counts and common blood biochemistry.

25 Complete blood counts and comparison of means and the pr

26 Complete blood counts and flow cytometric analyses were

27 visits and during outpatient care, including complete blood counts and hepatic and renal function tes

28 isk of immunodeficiency had peripheral blood complete blood counts and lymphocyte subsets assayed in

29 Blood samples were taken for complete blood counts and specific biochemicals in rats'

30 els, hepatitis C virus (HCV) RNA levels, and complete blood counts and underwent liver biopsy at the

31 al body iron, and transferrin], hematologic (complete blood count), and inflammatory (C-reactive prot

32 to a hospital laboratory for an urinalysis, complete blood count, and a standard blood chemistry pan

33 cal parameters, including fever, heart rate, complete blood count, and bacteremia; and evaluated the

34 othrombin time, partial thromboplastin time, complete blood count, and bleeding time were recorded.

35 ell, F/F cell, gamma-globin synthesis ratio, complete blood count, and chemistry were measured.

36 Subjects had undergone a phlebotomy, a complete blood count, and cognitive and dietary assessme

37 anoma progression with physical examination, complete blood count, and liver function tests every 3 m

38 ttery of medical tests (electrocardiography, complete blood count, and measurement of serum levels of

39 f the pulmonary circulation, pulse oximetry, complete blood count, and serum chemistries and pulmonar

40 teine (tHcy), and creatinine concentrations, complete blood count, and vitamin supplementation in 550

41 post-season to examine hemoglobin variants, complete blood counts, and chemistry panel 26.

42 Weight measurement, complete blood counts, and histopathology analysis were

43 rum and pulmonary cytokines, lung histology, complete blood counts, and intestinal proliferation were

44 Routine blood investigations, including complete blood counts, and liver, kidney, and thyroid fu

45 Weight, complete blood counts, and metabolites remained mostly w

46 Weight, complete blood counts, and metabolites were collected we

47 concentrations of ISATX247 and cyclosporine, complete blood counts, and serum chemistry profiles were

48 findings; laboratory test results, including complete blood count; and liver function test results we

49 findings; laboratory test results, including complete blood count; and liver function test results we

50 DNA level, HBsAg level, liver function test, complete blood count, aspartate aminotransferase-to-plat

51 eceived, and receipt of a bundle of 4 tests (complete blood count, basic metabolic profile, chest rad

52 k 64, changes in other PFASs, and changes in complete blood count, biochemistry, thyroid function, an

53 howed no evidence of changes in body weight, complete blood count, blood chemistry profile, cardiac c

54 ry evaluations for infection (urine culture, complete blood count, blood culture, and wound culture)

55 The final model included complete blood count, blood glucose, and oxygen saturati

56 The examination included complete blood count, blood smear microscopy, platelet f

57 iodistribution of the constituent materials, complete blood counts, blood chemistry and magnetic reso

58 Further work-up consisted of a complete blood count, bone marrow biopsy, and immunohist

59 Complete blood count, C-reactive protein level, sediment

60 rmountain Risk Score (IMRS), composed of the complete blood count (CBC) and basic metabolic profile (

61 Several parameters of preoperative complete blood count (CBC) and inflammation-associated b

62 esults from a 3-year period, with associated complete blood count (CBC) and liver function test resul

63 Hematological analysis, via a complete blood count (CBC) and microscopy, is critical f

64 ort analysis of adult patients who underwent complete blood count (CBC) and SARS-CoV-2 or influenza t

65 is per se was associated with alterations in complete blood count (CBC) and white blood cell (WBC) di

66 ) to classify microbiome, serum chemistry or complete blood count (CBC) data.

67 Complete Blood Count (CBC) is a collection of the most c

68 The complete blood count (CBC) is an important screening too

69 The complete blood count (CBC) provides a high-level assessm

70 We trained a model to predict PR from complete blood count (CBC) scattergrams.

71 aged 40 to 75 years on the date of a routine complete blood count (CBC) test (index test) who had a n

72 ex (SII) were obtained from the preoperative complete blood count (CBC) test and compared between the

73 However, the widely used Complete Blood Count (CBC) test presents challenges, inc

74 The ability to perform complete blood count (CBC) testing in at-home settings c

75 lth insurance plan who had 1 or more routine complete blood count (CBC) tests performed between Janua

76 Width (MDW), available as part of a routine complete blood count (CBC) with differential, may be a u

77 like high-performance liquid chromatography, Complete Blood Count (CBC) with peripheral smear, geneti

78 ocyte/monocyte-colony-forming unit (CFU-GM), complete blood count (CBC), and donor chimerism at vario

79 n saturation, comprehensive blood chemistry, complete blood count (CBC), and urinalysis.

80 Blood samples were taken and analyzed for complete blood count (CBC), erythrocyte sedimentation ra

81 um levels of Zn, Cu, ceruloplasmin, albumin, complete blood count (CBC), fasting blood sugar (FBS), A

82 Blood analyses included a complete blood count (CBC), sequential multiple analyzer

83 Complete blood count (CBC), serum chemistries, bile acid

84 participants received anemia education and a complete blood count (CBC).

85 tegrated centrifugal microfluidic device for complete blood counting (CBC) has not yet been fully rea

86 Clinical observations and complete blood counts (CBC) were performed.

87 investigate these differences, we evaluated complete blood counts (CBC), antibody binding of RBCs, T

88 Complete blood counts (CBC), proinflammatory cytokines,

89 ria were physician-ordered blood culture and complete blood count [CBC]), and 102 controls (healthy b

90 Complete blood counts (CBCs) were obtained on the day of

91 Body weights, complete blood counts (CBCs), and blood pressure were ob

92 Complete blood count changes, including new cell activat

93 The use of complete blood counts, chemistry panels, bone scans, che

94 The complete blood count clinical assay quantifies lymphocyt

95 ing immune complexes, complement activation, complete blood counts, cytokine/chemokine, and gene expr

96 lection of samples of instances from routine complete blood count data in such a way that each observ

97 co-infections with dengue virus, one missing complete blood count data) and two participants who were

98 articipants who were non-Zika cases (missing complete blood count data) were excluded from analysis.

99 .g., MCP-counter, xCell, EPIC, quanTIseq) to complete blood count data, the current gold standard in

100 a standard battery of 18 biochemical tests, complete blood counts, disease complications, duration o

101 monary artery catheter insertions; number of complete blood counts, electrolytes, and cultures sent f

102 Complete blood count, erythrocyte sedimentation rate, C-

103 valuation regardless of the type of uveitis (complete blood count, erythrocyte sedimentation rate, C-

104 overy of BM stem and progenitor cells and of complete blood counts following irradiation.

105 The patient underwent serial measurements of complete blood count, hepatic profile, coagulation profi

106 Of those, 9,061 users also self-reported complete blood count Hgb levels for comparison, resultin

107 cute clinical findings (signs, symptoms, and complete blood counts) in both Zika cases and non-Zika c

108 Additionally, a complete blood count, including differential leukocyte c

109 Complete blood count indices and their ratios are associ

110 According to complete blood count, leukocyte, monocyte and platelet c

111 s in the immunized macaques, as indicated by complete blood counts, leukocyte differentials and hepat

112 Complete blood counts, liver and renal function test res

113 We collected complete blood counts, lymphocyte subsets, and infection

114 Additional evaluations included complete blood count, markers of inflammation, and serum

115 that age-specific likelihood values for the complete blood count may determine risk of infection.

116 ypochromic microcytic anemia pattern seen in complete blood count (MCV 70.2 fl, MCH 21.4 pg).

117 rn, number of patients with various abnormal complete blood count measurements, and location-specific

118 rs are adaptively identified using recurrent complete blood count measurements, which sufficiently co

119 ngs of routine laboratory testing, including complete blood count, metabolic panel with electrolytes,

120 ults of routine laboratory workup, including complete blood count, metabolic panel, and high-sensitiv

121 nts identified as having coexistent disease, complete blood counts, multiphasic biochemical testing,

122 analyzed in patients with available baseline complete blood counts (n=3717).

123 For the complete blood count, no significant differences were ob

124 lished that gammaP-122-I affects neither the complete blood count nor biochemical tests of liver and

125 labeling efficiency, in vitro stability, or complete blood count of leukocytes labeled with stabiliz

126 Complete blood counts of all three of our patients revea

127 ts of Star:Star-mPEG/antimiR-145 with serial complete blood counts of leukocytes and serum metabolic

128 IFN-alpha, liver and kidney function tests, complete blood counts, or pathology of major organs are

129 y analysis revealed that, except for anemia, complete blood count parameters were within normal limit

130 for ID assessments, save time and cost using complete blood count parameters, while standardizing int

131 more predictive of the clinical course than complete-blood-count parameters.

132 We included people 30 years or older with complete blood counts performed in usual clinical care a

133 5,231 individuals in the cohort, 154,179 had complete blood counts performed under acute conditions a

134 Complete blood counts, plasma interleukin-6 (IL-6) level

135 es not affect hematopoiesis as determined by complete blood count profiles.

136 but all other laboratory findings, including complete blood count, renal function, liver function, vi

137 but all other laboratory findings, including complete blood count, renal function, liver function, vi

138 Complete blood counts, renal and liver function assessme

139 A basic serum chemistry test and complete blood count revealed no abnormal findings.

140 Analysis of complete blood counts revealed a median hemoglobin level

141 Recipients were followed up with daily complete blood count, scheduled chest radiographs, and b

142 Blood samples were analyzed for complete blood count, serum chemistry profile, level of

143 nical examination, routine laboratory tests (complete blood count, serum creatinine level), urine alb

144 included: a) the tests to be obtained daily: complete blood count, serum electrolytes, urea nitrogen,

145 whole-mouth clinical periodontal parameters, complete blood count, smoking status, and age.

146 They are monitored clinically by complete blood counts, specifically with measurements of

147 use of the improved survival was unclear, as complete blood counts, splenic and marrow cellularity, n

148 resulted in significant weight loss and the complete blood count suggested the development of anemia

149 ied by para-phenylenediamine staining, and a complete blood count system was used to measure the numb

150 nical information (e.g., metabolic panel and complete blood count test results).

151 th negligible/negative (< 1%) yield included complete blood counts (therapy-related leukemia), dipsti

152 ecent rejection episode, cyclosporine level, complete blood count, time between transplantation and o

153 ated with BTNPs showed better restoration of complete blood count to normal level, and significantly

154 Complete blood counts to measure total eosinophils, frac

155 24 children with SCA with a neurologic exam, complete blood count, transcranial Doppler ultrasound (T

156 ical history and laboratory tests, including complete blood count, transferrin saturation, and other

157 We then examined complete blood count values in the electronic health rec

158 A complete blood count was carried out in all UK Biobank p

159 Complete blood count was normal.

160 ed at 1 and 3 h after preparation, whereas a complete blood count was obtained at 3 h after preparati

161 A complete blood count was obtained.

162 Blood chemistries, complete blood count, weight, liver, and kidney biopsies

163 ferritin level, routine chemistry panel, and complete blood count were determined.

164 Changes in the complete blood count were mild despite severe bone marro

165 The comprehensive metabolic panel and complete blood count were normal throughout and after th

166 Histology and complete blood counts were analyzed in naive C57BL/6 mic

167 Complete blood counts were available for four patients,

168 TPO plus G-CSF or vehicle and complete blood counts were measured.

169 Complete blood counts were monitored for 60 days postirr

170 Complete blood counts were monitored for 60 days postirr

171 Liver chemistries and complete blood counts were monitored, and patients were

172 Complete blood counts were normal or near normal in all

173 no history of underlying malignancy, and the complete blood counts were normal.

174 stem cell transplantation, peripheral blood complete blood counts were performed and examined for po

175 Complete blood counts were performed every 2 years.

176 luding biochemistry, electrolyte levels, and complete blood count, were all within normal limits, exc

177 luding biochemistry, electrolyte levels, and complete blood count, were all within normal limits, exc

178 sment of renal function, liver function, and complete blood count, were within normal limits.

179 taken at baseline and at study completion; a complete blood count with differential and comprehensive

180 At endpoint, whole blood was assessed via a complete blood count with differential and immunophenoty

181 The complete blood count with differential revealed that mos

182 a thorough history and physical examination, complete blood count with differential, chest x-ray, uri

183 Complete blood count with differential, serology screen

184 hematology analyzer during performance of a complete blood count with differential.

185 (eg, hematocrit), available in an outpatient complete blood count without differential, would be usef